Inicio › Cáncer de pulmón › Massachusetts

Ensayos clínicos de Cáncer de pulmón en Massachusetts

76 estudios sobre Cáncer de pulmón buscan participantes en Massachusetts.

Ciudades en Massachusetts

Texto oficial del estudio (inglés)

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Reliant Medical Group Inc, Worcester

ReclutandoFase 3

Edades de 18 a 100 · Todos los sexos · Actualizado el 13 nov 2026 · NCT05920356

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Dana-Farber Cancer Institute, Boston

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT07063745

EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations

Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston
Massachusetts General Hospital, Boston
y 3 más

ReclutandoSe aceptan voluntarios sanos

Edades de 40 a 80 · Todos los sexos · Actualizado el 13 nov 2026 · NCT06716580

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Dana-Farber Cancer Institute, Boston

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07100080

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Southcoast Centers for Cancer Care, Fairhaven
Southcoast Centers for Cancer Care, Fall River

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06758401

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Beverly Hospital, Beverly
Lahey Clinic, Burlington
Addison Gilbert Hospital, Gloucester
y 3 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06498635

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Beverly Hospital, Beverly
Boston Medical Center, Boston
Beth Israel Deaconess Medical Center, Boston
y 8 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT04267848

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Tufts Medical Center, Boston
Dana-Farber Cancer Institute at Boston Medical Center - Brighton, Brighton
Dana-Farber Cancer Institute at Foxborough, Foxborough
y 3 más

ReclutandoFase 3

Edades de 70 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06096844

A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Mass General Brigham Cancer Institute at Massachusetts General Hospital, Boston

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07458347

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Massachusetts General Hospital, Boston

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT07020221

Health Opportunities and Promoters of Equitable Screening for Lung Cancer

Massachusetts General Hospital, Boston

ReclutandoEstudio observacional

Edades de 50 a 80 · Todos los sexos · Actualizado el 9 nov 2026 · NCT05784922

Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer

Massachusetts General Hospital, Boston

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06791057

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Massachusetts General Hospital, Boston
University of Massachusetts Memorial Medical Center, Worcester

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06793215

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

UMass Memorial Medical Center - University Campus, Worcester

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT04181060

A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Local Institution - 0124, Boston

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07492680

Distance-Based Exercise to Preserve Function and Prevent Disability

Dana-Farber Cancer Institute, Boston

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07059884

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Boston Medical Center, Boston
Lahey Hospital & Medical Center, Burlington

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06119581

Preliminary Efficacy of Different Exercise Training During Immunotherapy in Patients With Lung Cancer: The ENHANCE Trial

Dana-Farber Cancer Institute, Boston

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT06026111

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Research Site, Boston
Research Site, Boston

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT06835569

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT02984761

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT06922591

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site, Boston

ReclutandoFase 2

Edades de 18 a 95 · Todos los sexos · Actualizado el 21 oct 2026 · NCT05061550

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Dana Farber Cancer Institute, Boston

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 oct 2026 · NCT06810544

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Dana-Farber Cancer Institute, Boston

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06244771

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Dana Farber Cancer Institute, Boston

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06162221

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Boston

ReclutandoFase 1/2

Edades de 18 a 75 · Todos los sexos · Actualizado el 16 oct 2026 · NCT07038343

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Beth Israel Lahey Health - Lahey Hospital & Medical Center (LHMC), Lahey Clinic Medical Center, Burlington

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT06712355

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Dana-Farber Cancer Institute, Boston

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT05786924

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Dana Farber Cancer Institute, Boston

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT06293898

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Lahey Clinic, Burlington
UMass Memorial Medical Center - University Campus, Worcester

ReclutandoFase 2

18 Minutes · Todos los sexos · Actualizado el 9 oct 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Beverly Hospital, Beverly
Lahey Clinic, Burlington
Addison Gilbert Hospital, Gloucester
y 3 más

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT06616584

DNA Analysis of Blood and Tissue From Patients With Lung Cancer

Massachusetts General Hospital, Boston
Harvard School of Public Health, Boston

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 18 a 120 · Todos los sexos · Actualizado el 7 oct 2026 · NCT00471978

Boston Lung Cancer Study (Molecular and Genetic Analysis of Lung Cancer)

Massachusetts General Hospital, Boston

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 7 oct 2026 · NCT03029325

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Massachusetts General Hospital, Boston
Dana-Farber Cancer Insitute, Boston

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06625775

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Dana-Farber Cancer Institute, Boston

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT06765109

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site, Boston

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07127874

A Registry for People With Lung Cancer

Massachusetts General Hospital Cancer Center (Data Collection Only), Boston
Brigham and Women's Hospital (Data Collection Only), Boston

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT06424327

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Dana Farber Cancer Institute, Boston

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06128551

A Community Health Intervention to Improve Lung Cancer Screening Uptake in Community Health Centers

Baystate Health, Springfield

ReclutandoSe aceptan voluntarios sanos

Edades de 50 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07168629

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.